| 英文别名： |
Gestonoronacetat;17-Acetoxy-19-norpregn-4-ene-3,20-dione;17-Hydroxy-19-norpregn-4-ene-3,20-dione 17-acetate;(17alpha)-17-acetyl-3-oxoestr-4-en-17-yl acetate;17alpha-Hydroxy-19norprogesterone-17alpha acetate;17alpha-Hydroxy-19-norprogesterone-17alpha acetate;19-Nor-17alpha-hydroxyprogesterone acetate;19-Norpregn-4-ene-3,20-dione, 17-alpha-hydroxy-, acetate;RC89606500;17-Acetoxy-19-norprogesterone;EINECS 250-882-8;(8R,9S,10R,13S,14S,17R)-17-Acetyl-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylacetate;SCHEMBL10954178;(8R,9S,10R,13S,14S,17R)-17-Acetyl-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate;AKOS015896562;Gestonoronacetate;EC 250-882-8;UNII-D9R4KSN7NA;acetic acid [(8R,9S,10R,13S,14S,17R)-17-acetyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] ester;DTXSID90953874;[(8R,9S,10R,13S,14S,17R)-17-ethanoyl-13-methyl-3-oxidanylidene-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] ethanoate;17alpha-Acetoxy-19-norprogesterone;19-Norpregn-4-ene-3,20-dione, 17-hydroxy-, acetate;17.ALPHA.-ACETOXY-19-NORPROGESTERONE;BCP17003;[(8R,9S,10R,13S,14S,17R)-17-acetyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;NS00003690;D9R4KSN7NA;NIOSH/RC8960650;17-Acetyl-3-oxoestr-4-en-17-yl acetate #;MTSLFKWJINJVBO-ZCPXKWAGSA-N;31981-44-9;A821085;17-alpha-Acetoxy-19-norprogesterone;19-Norpregn-4-ene-3,20-dione, 17-(acetyloxy)-;17-alpha-Hydroxy-19-norpregn-4-ene-3,20-dione acetate |
沪公网安备 
